View in EDS

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

Saved in:
Bibliographic Details
Title: PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Authors: Guerin, Mathilde1, Rezai, Keyvan2, Isambert, Nicolas3, Campone, Mario4, Autret, Aurélie5, Pakradouni, Jihane5, Provansal, Magali1, Camerlo, Jacques1, Sabatier, Renaud1, Bertucci, François1, Charafe-Jauffret, Emmanuelle6, Hervieu, Alice3, Extra, Jean-Marc1, Viens, Patrice1, Lokiec, François2, Boher, Jean-Marie5,7, Gonçalves, Anthony1 goncalvesa@ipc.unicancer.fr
Source: European Journal of Cancer. Nov2017, Vol. 86, p28-36. 9p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2017.08.025